5L
BIIB icon

55I LLC’s Biogen BIIB Stock Holding History

55I LLC’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$529K Buy
+1,983
New +$421K 0.01% 365

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

55I LLC's BIIB Position: Q3 2022 in Review

55I LLC opened a new position in Biogen (BIIB) in Q3 2022: 1,983 shares worth $529K. The stake represents 0.01% of the portfolio and ranks #365 among its holdings.

986 funds tracked by Wall St. Rank hold BIIB as of Q3 2022.

  • 55I LLC held 1,983 shares of Biogen worth $529K as of Q3 2022.
  • Biogen was a new 55I LLC position in Q3 2022.
  • Biogen made up 0.01% of 55I LLC's portfolio in Q3 2022, its #365 holding.
  • 986 funds tracked by Wall St. Rank held Biogen as of Q3 2022.

Based on 55I LLC's 13F filing for Q3 2022, filed 14 Nov 2022.